C3.ai Inc vs Citius Pharmaceuticals Inc — how do they compare? C3.ai Inc trades at $10.52 (market cap $1.65B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: C3.ai Inc is far larger — about 82.5× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AI | CTXR | |
|---|---|---|
Market Cap | $1.65B | $20.01M |
Sector | Technology | Health |
52-Week High | $19.66 | $1.82 |
52-Week Low | $7.76 | $0.48 |
Enterprise Value | $1.08B | $16.23M |
Trailing returns across standard periods
Latest headlines on both assets
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →